Zhi Li (Jeffrey)

Zhi (Jeffrey) Li is the Managing Partner at CLI Ventures, and also serves as an advisor and board member at Correlation Biosciences. Additionally, Zhi (Jeffrey) Li has been an investor in several prominent companies including Compass Therapeutics Inc., Guardant Health, CRISPR Therapeutics, Turning Point Therapeutics, Immune-Onc Therapeutics, Neocis Inc., and Genalyte, Inc. Zhi (Jeffrey) Li holds a Master of Science degree in Experimental and Translational Therapeutics from the University of Oxford, and a Master of Business Administration (MBA) in Finance from Fordham Gabelli School of Business.